Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123501545 | 12350154 | 5 | F | 20160712 | 20160510 | 20160722 | PER | PHEH2016US011024 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160722 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123501545 | 12350154 | 1 | PS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | U | S00015A,S0017A | 125504 | 300 | MG | INJECTION | /month | ||||
| 123501545 | 12350154 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 123501545 | 12350154 | 3 | SS | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0.05 MG, QD | 0 | .05 | MG | QD | |||||||
| 123501545 | 12350154 | 4 | C | NEXIUM I.V. | ESOMEPRAZOLE SODIUM | 1 | Oral | 40 MG, QOD | U | 0 | 40 | MG | |||||||
| 123501545 | 12350154 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 123501545 | 12350154 | 6 | C | Calcium | CALCIUM | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 123501545 | 12350154 | 7 | C | LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS | 1 | Oral | UNK UNK, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123501545 | 12350154 | 1 | Psoriasis |
| 123501545 | 12350154 | 2 | Product used for unknown indication |
| 123501545 | 12350154 | 3 | Product used for unknown indication |
| 123501545 | 12350154 | 4 | Product used for unknown indication |
| 123501545 | 12350154 | 5 | Product used for unknown indication |
| 123501545 | 12350154 | 6 | Product used for unknown indication |
| 123501545 | 12350154 | 7 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123501545 | 12350154 | Drug ineffective | |
| 123501545 | 12350154 | Dry skin | |
| 123501545 | 12350154 | Psoriasis | |
| 123501545 | 12350154 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123501545 | 12350154 | 1 | 20160122 | 0 |